Kalaris Therapeutics (KLRS) Shares Outstanding (Diluted) (2021 - 2026)
Kalaris Therapeutics (KLRS) reported Shares Outstanding (Diluted) of 23.8 million for Q2 2026, up 27.2% from 18.7 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Kalaris Therapeutics posted Shares Outstanding (Diluted) of 15.27 million, up 204.8% from FY2024.
- Shares Outstanding (Diluted) has a four-year compound annual growth rate of -29.8% (FY2021 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 5.01 million in FY2024 (-95.2%), 104.06 million in FY2023 (+35.7%), 76.65 million in FY2022 (+22.1%) and 62.78 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) since Q3 2024.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last three quarters, with growth averaging 44.9% over the last eight quarters.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q1 2026 (growth of 485.3%); the low point was Q1 2025 (a decline of 96.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 23.72 million (Q1 2026), 15.27 million (Q4 2025) and 18.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | 23.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.80 Mn |
| Mar 31, 2026 | 23.72 Mn |
| Dec 31, 2025 | 15.27 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 18.70 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Sep 30, 2024 | 115.40 Mn |
| Jun 30, 2024 | 115.13 Mn |
| Mar 31, 2024 | 114.69 Mn |
| Dec 31, 2023 | 104.06 Mn |
| Sep 30, 2023 | 113.89 Mn |
| Jun 30, 2023 | 94.63 Mn |
| Mar 31, 2023 | 93.30 Mn |
| Dec 31, 2022 | 76.65 Mn |
| Sep 30, 2022 | 84.95 Mn |
| Jun 30, 2022 | 64.47 Mn |
| Mar 31, 2022 | 63.99 Mn |
| Dec 31, 2021 | 62.78 Mn |
| Sep 30, 2021 | 62.96 Mn |
API Access
Kalaris Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();